Associate Professor of Urology, University Kansas
Urology
Dr. Jeffrey M. Holzbeierlein, MD
|
|
Give Review
Jeffrey M. Holzbeierlein, MD practices Urology. He researched medicine at University of Oklahoma College of Medicine. He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)", "Top MD" and "Super Doctor". Jeffrey Holzbeierlein is also published. He has 54 publications published. The lastest publication: "Effects of Immunonutrition for Cystectomy on Immune Response and Infection Rates: A Pilot Randomized Controlled Clinical Trial.' He is registered with Medicare.
Publications
- Effects of Immunonutrition for Cystectomy on Immune Response and Infection Rates: A Pilot Randomized Controlled Clinical Trial.
- Hsp90 C-Terminal Inhibitors Exhibit Antimigratory Activity by Disrupting the Hsp90α/Aha1 Complex in PC3-MM2 Cells.
- The Effect of Concomitant Carcinoma in Situ on Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma of the Bladder: Inferior Pathologic Outcomes, But No Effect on Su...
- Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in 11C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence.
- Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors.
- Patient-Centered Perspectives on the Access to Educational Opportunities Specific to Lifestyle Modification in Men at Risk for Primary or Secondary Prostate Cancer.
- Development of a high-throughput screening Cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitors.
- Radical prostatectomy does not improve survival compared to observation for localised prostate Cancer in a prospective randomised trial.
- Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate Cancer.
- Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate Cancer cells.
- A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients.
- Prostate imaging modalities that can be used for complementary and alternative medicine clinical studies.
- Circumaortic Renal vein tumor thrombus in Renal cell carcinoma.
- The perioperative management of an inferior vena caval tumor thrombus in patients with Renal cell carcinoma.
- Hsp90: a drug target?
- Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate Cancer cells.
- Review of the bylaws changes from the Society of Urologic Oncology 2009.
- Adjuvant radiation therapy after radical Prostatectomy: when is it indicated?
- Digital fecal occult Blood testing in the ambulatory urology clinic.
- Finasteride as a chemopreventive agent in prostate Cancer: impact of the PCPT on urologic practice.
- Evaluation of ureterointestinal anastomosis: Wallace vs Bricker.
- Managing complications of androgen deprivation therapy for prostate Cancer.
- Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
- The craft of urologic surgery: modern radical perineal Prostatectomy.
- Complications of androgen deprivation therapy for prostate Cancer.
- Complications of androgen deprivation therapy: prevention and treatment.
- Complications of androgen-deprivation therapy for prostate Cancer.
- Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001.
- Leukemoid reaction and autocrine growth of Bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor - a potential neoplastic marker...
- Short-term soy isoflavone intervention in patients with localized prostate Cancer: a randomized, double-blind, placebo-controlled trial.
- Radical Prostatectomy and collaborative care pathways.
- The urodynamic profile of myelodysplasia in childhood with spinal closure during gestation.
- Right Ureteral injury after radiofrequency ablation for atrial fibrillation.
- Surgical management of noninvasive Bladder cancer (stages Ta/T1/CIS).
- Abnormal mammogram as the presenting sign of Renal cell carcinoma.
- Variability of results of cavernous nerve stimulation during radical Prostatectomy.
- Gene expression analysis of human Prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.
- Hsp90 inhibitors identified from a library of novobiocin analogues.
- Long-term followup of metastatic prostate Cancer.
- Case selection and outcome of radical perineal prostatectomy in localized prostate Cancer.
- Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in Renal cell carcinoma.
- What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?
- Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in Renal cell carcinoma.
- Dose effect of soy supplementation in prostate Cancer: a pilot study.
- Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate Cancer.
- Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate Cancer cells.
- The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity.
- Development of novobiocin analogues that manifest anti-proliferative activity against several Cancer cell lines.
- Active surveillance for prostate Cancer in a veteran population.
- Management of the contralateral testicle in patients with unilateral testicular Cancer.
- Engineering an antibiotic to fight Cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents.
- Dual antigen target-based immunotherapy for prostate Cancer eliminates the growth of established tumors in mice.
- Targeting the heat shock protein 90 dimer with dimeric inhibitors.
Schools
University Of Oklahoma College Of Medicine
Vanderbilt Med Center
Meml Sloan Kettering Canc Center
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystometry
- View All
Conditions Treated
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Top MD
- Super Doctor
Education
-
Vanderbilt University -
University of Oklahoma College of Medicine
Hospital
-
The University of Kansas Hospital
Drug Facts
| NPI NUMBER | 1366546780 | |
| NPPES Provider LastName | HOLZBEIERLEIN | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 66160 | |
| NPPES Provider State | KS | |
| Specialty Description | Urology | |
| Total Claim Count | 413.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366546780 |
| Last Name Of The Provider | HOLZBEIERLEIN |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. David A. Duchene, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tomas L. Griebling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J B. Thrasher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Travis W. Dum, MD |
|
|
Dr. William P. Parker, MD |
|
|
Dr. Andrew P. Windsperger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew R. Arther, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley A. Wilson, MD |